Immunocore Holdings plc (FRA:6YG)
Germany flag Germany · Delayed Price · Currency is EUR
24.00
-1.00 (-4.00%)
Last updated: Jun 3, 2026, 7:55 PM CET

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $106.68M USD in the quarter ending March 31, 2026, with 13.63% growth. This brings the company's revenue in the last twelve months to $412.81M, up 23.75% year-over-year. In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth.

Revenue (ttm)
$412.81M
Revenue Growth
+23.75%
P/S Ratio
3.61
Revenue / Employee
$787.81K
Employees
524
Market Cap
1.29B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M215.75M640.71%
Dec 31, 202233.67M-2.81M-7.70%
Dec 31, 202136.48M-4.69M-11.39%
Dec 31, 202041.17M7.13M20.95%
Dec 31, 201934.04M3.91M12.98%
Dec 31, 201830.13M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biotest GmbH & Co. KGaA635.20M
Darwin AG54.30M
Paion AG14.81M
2invest AG8.89M
MagForce AG1.08M
Biomark Diagnostics57.01K
co.don AG22.00K
bioXXmed AG20.49K
Revenue Rankings